Cidara Therapeutics, Inc.
Records under this name other than the patents Cidara Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to Cidara Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,217,014 | Antifungal Agents and Uses Thereof now held by Napp Pharmaceutical Group Limited In force · High confidence | In force | High confidence | |
| US 9,676,821 | Antifungal Agents and Uses Thereof now held by Napp Pharmaceutical Group Limited In force · High confidence | In force | High confidence | |
| US 11,654,196 | Dosing Regimens for Echinocandin Class Compounds now held by Napp Pharmaceutical Group Limited In force · High confidence | In force | High confidence | |
| US 9,526,835 | Dosing Regimens for Echinocandin Class Compounds now held by Napp Pharmaceutical Group Limited In force · High confidence | In force | High confidence | |
| US 10,016,479 | Dosing Regimens for Echinocandin Class Compounds now held by Napp Pharmaceutical Group Limited In force · High confidence | In force | High confidence | |
| US 10,702,573 | Dosing Regimens for Echinocandin Class Compounds now held by Napp Pharmaceutical Group Limited In force · High confidence | In force | High confidence | |
| US 12,344,680 | Antifungal Agents and Uses Thereof now held by Napp Pharmaceutical Group Limited In force · High confidence | In force | High confidence | |
| US 8,722,619 | Antifungal Agents and Uses Thereof now held by Napp Pharmaceutical Group Limited In force · High confidence | In force | High confidence | |
| US 10,369,188 | Methods for Preventing and Treating Pneumocystis Infections now held by Napp Pharmaceutical Group Limited In force · High confidence | In force | High confidence | |
| US 10,780,144 | Methods for Preventing and Treating Pneumocystis Infections now held by Napp Pharmaceutical Group Limited In force · Medium confidence | In force | Medium confidence |